Fundz

Xylocor Therapeutics, Inc. reported raising $100,000 in an initial SEC Form D filing, from an offering of $100,000

PRIVATEDec 06, 2017

Amount Raised

$100,000

$100,000 sold, per SEC Form D (first sale Dec 6, 2017)

Round Type

Pre-Seed

MalvernBiotechnology

Quick answer

XyloCor Therapeutics, Inc. raised $100,000 in a Pre-Seed round, dated December 6, 2017. XyloCor Therapeutics, Inc. is based in Malvern, Pennsylvania, United States.

How much did XyloCor Therapeutics, Inc. raise?
XyloCor Therapeutics, Inc. raised $100,000 in a Pre-Seed round on December 6, 2017.
What does XyloCor Therapeutics, Inc. do?
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
Where is XyloCor Therapeutics, Inc. based and how big is it?
XyloCor Therapeutics, Inc. is based in Malvern, Pennsylvania, United States. Fundz records about 16 employees.
Who are the decision-makers at XyloCor Therapeutics, Inc?
Fundz holds 1 contact at XyloCor Therapeutics, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as XyloCor Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CytoDel, INC. raised $3.9M (Seed) on January 17, 2018.
  • SAVICELL raised $200K (Pre-Seed) on January 17, 2018.
  • IGM Biosciences A/S raised $2.1M (Seed) on January 16, 2018.
  • EpigenCare Inc. raised an undisclosed amount on January 16, 2018.
  • Cresilon raised $13M on January 12, 2018.
  • Pear Therapeutics, Inc. raised $46M on January 12, 2018.

Who to call at XyloCor Therapeutics, Inc., and when

A new round usually means XyloCor Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day XyloCor Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at XyloCor Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at XyloCor Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

XyloCor Therapeutics, Inc.

Location

39 Addison Lane

Malvern, Pennsylvania, United States

About

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment XyloCor Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEric D., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for XyloCor Therapeutics, Inc.'s next move

See what Strategic adds

XyloCor Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.